Morphological, cellular, and molecular basis of brain infection in COVID-19 patients
Although increasing evidence confirms neuropsychiatric manifestations associated mainly with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently characterized as part of "long COVID-19" syndrome) has been frequently observed after mild infection. We show the spectrum of cerebral impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, ranging from long-term alterations in mildly infected individuals (orbitofrontal cortical atrophy, neurocognitive impairment, excessive fatigue and anxiety symptoms) to severe acute damage confirmed in brain tissue samples extracted from the orbitofrontal region (via endonasal transethmoidal access) from individuals who died of COVID-19. In an independent cohort of 26 individuals who died of COVID-19, we used histopathological signs of brain damage as a guide for possible SARS-CoV-2 brain infection and found that among the 5 individuals who exhibited those signs, all of them had genetic material of the virus in the brain. Brain tissue samples from these five patients also exhibited foci of SARS-CoV-2 infection and replication, particularly in astrocytes. Supporting the hypothesis of astrocyte infection, neural stem cell-derived human astrocytes in vitro are susceptible to SARS-CoV-2 infection through a noncanonical mechanism that involves spike-NRP1 interaction. SARS-CoV-2-infected astrocytes manifested changes in energy metabolism and in key proteins and metabolites used to fuel neurons, as well as in the biogenesis of neurotransmitters. Moreover, human astrocyte infection elicits a secretory phenotype that reduces neuronal viability. Our data support the model in which SARS-CoV-2 reaches the brain, infects astrocytes, and consequently, leads to neuronal death or dysfunction. These deregulated processes could contribute to the structural and functional alterations seen in the brains of COVID-19 patients.
Authors
Crunfli F, Carregari VC, Veras FP, et al.
External link
Publication Year
Publication Journal
Associeted Project
Systems Immunology of Human Diseases
Lista de serviços
-
As antisense RNA gets intronic.As antisense RNA gets intronic.
-
Androgen responsive intronic non-coding RNAs.Androgen responsive intronic non-coding RNAs.
-
Conserved tissue expression signatures of intronic noncoding RNAs transcribed from human and mouse loci.Conserved tissue expression signatures of intronic noncoding RNAs transcribed from human and mouse loci.
-
The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.
-
Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer.Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer.
-
Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection.Insight Into the Long Noncoding RNA and mRNA Coexpression Profile in the Human Blood Transcriptome Upon Leishmania infantum Infection.
-
Long non-coding RNAs associated with infection and vaccine-induced immunityLong non-coding RNAs associated with infection and vaccine-induced immunity
-
Comparative transcriptomic analysis of long noncoding RNAs in Leishmania-infected human macrophagesComparative transcriptomic analysis of long noncoding RNAs in Leishmania-infected human macrophages